These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14662887)

  • 41. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.
    Bessis N; Guéry L; Mantovani A; Vecchi A; Sims JE; Fradelizi D; Boissier MC
    Eur J Immunol; 2000 Mar; 30(3):867-75. PubMed ID: 10741403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
    J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
    Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
    Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human colon carcinomas constitutively express and shed type II IL-1 receptor, an IL-1 antagonist.
    Stadnyk AW; Yeung MM; Yan SR
    Dig Dis Sci; 2003 Sep; 48(9):1737-44. PubMed ID: 14560993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity.
    McNamee EN; Ryan KM; Kilroy D; Connor TJ
    Eur J Pharmacol; 2010 Jan; 626(2-3):219-28. PubMed ID: 19818755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor necrosis factor-alpha (TNF-alpha)-induced and interleukin-1 beta (IL-1 beta)-induced shedding of TNF receptors from gingival fibroblasts.
    Ohe H; Takashiba S; Naruishi K; Chou HH; Yamada H; Nishimura F; Arai H; Murayama Y
    J Interferon Cytokine Res; 2000 Dec; 20(12):1077-82. PubMed ID: 11152574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of TNF-alpha processing and TACE-mediated ectodomain shedding by ethanol.
    Zhang Z; Cork J; Ye P; Lei D; Schwarzenberger PO; Summer WR; Shellito JE; Nelson S; Kolls JK
    J Leukoc Biol; 2000 Jun; 67(6):856-62. PubMed ID: 10857859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils.
    Xing L; Remick DG
    Shock; 2003 Jul; 20(1):10-6. PubMed ID: 12813362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors.
    Hawari FI; Rouhani FN; Cui X; Yu ZX; Buckley C; Kaler M; Levine SJ
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1297-302. PubMed ID: 14745008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Staphylococcus aureus Induces Shedding of IL-1RII in Monocytes and Neutrophils.
    Giai C; Gonzalez CD; Sabbione F; Garofalo A; Ojeda D; Sordelli DO; Trevani AS; Gómez MI
    J Innate Immun; 2016; 8(3):284-98. PubMed ID: 26967533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of bovine interleukin-1 receptors.
    Yu PW; Schuler LA; Rejman JJ; Chen HT; Gosink K; Kehrli M; Mattocks L; Nonnecke B; Czuprynski CJ
    Vet Immunol Immunopathol; 1998 May; 63(1-2):21-5. PubMed ID: 9656437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
    Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
    Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of IL-1 beta to IL-1R type II at single cell level.
    Stoppacciaro A; Bossu P; Ghiara P; Ruco LP; Censini S; Scapigliati G; Nuti S; Tagliabue A; Baroni CD; Boraschi D
    J Immunol; 1991 Sep; 147(5):1561-6. PubMed ID: 1831828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist.
    Mortier E; Bernard J; Plet A; Jacques Y
    J Immunol; 2004 Aug; 173(3):1681-8. PubMed ID: 15265897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of the IL-1RII decoy receptor by NFAT/FOXP3 blocks IL-1β-dependent response of Th17 cells.
    Kim DH; Kim HY; Cho S; Yoo SJ; Kim WJ; Yeon HR; Choi K; Choi JM; Kang SW; Lee WW
    Elife; 2021 Jan; 10():. PubMed ID: 33507149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
    Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
    Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences between disease-associated endoplasmic reticulum aminopeptidase 1 (ERAP1) isoforms in cellular expression, interactions with tumour necrosis factor receptor 1 (TNF-R1) and regulation by cytokines.
    Yousaf N; Low WY; Onipinla A; Mein C; Caulfield M; Munroe PB; Chernajovsky Y
    Clin Exp Immunol; 2015 May; 180(2):289-304. PubMed ID: 25545008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.